Berenberg Bank Reiterates “Buy” Rating for Evoke (LON:EVOK)

Evoke (LON:EVOKGet Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Berenberg Bank in a research note issued on Wednesday, MarketBeat Ratings reports. They currently have a GBX 95 ($1.29) price objective on the stock. Berenberg Bank’s price target suggests a potential upside of 54.98% from the company’s current price.

Separately, JPMorgan Chase & Co. increased their price objective on Evoke from GBX 77 ($1.04) to GBX 80 ($1.08) and gave the company a “neutral” rating in a research report on Thursday, July 10th.

View Our Latest Stock Report on EVOK

Evoke Trading Down 3.5%

LON EVOK opened at GBX 61.30 ($0.83) on Wednesday. Evoke has a 12 month low of GBX 36.70 ($0.50) and a 12 month high of GBX 77.80 ($1.05). The stock has a market cap of £273.39 million, a P/E ratio of -1.53 and a beta of 0.84. The stock’s fifty day moving average price is GBX 63.19 and its 200-day moving average price is GBX 60.30.

Evoke (LON:EVOKGet Free Report) last released its earnings results on Wednesday, August 13th. The company reported GBX 1.20 ($0.02) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, analysts forecast that Evoke will post 12.7648305 earnings per share for the current fiscal year.

Insider Buying and Selling at Evoke

In other news, insider Per Widerström purchased 68,958 shares of the business’s stock in a transaction on Friday, May 23rd. The stock was acquired at an average cost of GBX 54 ($0.73) per share, for a total transaction of £37,237.32 ($50,381.98). Also, insider Sean Wilkins purchased 31,659 shares of the business’s stock in a transaction on Friday, May 23rd. The shares were purchased at an average price of GBX 54 ($0.73) per share, with a total value of £17,095.86 ($23,130.65). Company insiders own 27.00% of the company’s stock.

Evoke Company Profile

(Get Free Report)

Featured Articles

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.